Open access
Aug 2026
Reversing KDM6A phosphorylation-driven epigenetic suppression restores pyroptosis and synergizes with anti-PD-1 therapy in HNSCC
KDM6A phosphorylation is identified as a druggable epigenetic-immune checkpoint and mRNA-based modulation of enzyme post-translational status as a transformative paradigm to potentiate ICB in HNSCC is established.
Yi-Kang Ji, Xin-Ran Zhao, Cheng Hu et al.
· Cell Death & Disease · 0 citations